Logo image of MNPR

MONOPAR THERAPEUTICS INC (MNPR) Stock Analyst Earnings Estimates

NASDAQ:MNPR - Nasdaq - US61023L2079 - Common Stock - Currency: USD

40.65  +0.2 (+0.49%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MNPR revenue by date.MNPR revenue by date.
N/AN/AN/A
1,955.42%		N/A
168.64%		N/A
45.70%		N/A
28.93%		N/A
38.44%		N/A
49.49%
EBITDA
YoY % growth
MNPR ebitda by date.MNPR ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MNPR ebit by date.MNPR ebit by date.
-1.19M-16.6M
-1,294.96%		-3.33M
79.94%		-4.32M
-29.73%		-6.51M
-50.69%		-9.13M
-40.25%		-10.54M
-15.44%		-8.83M
16.22%		-16M
-81.20%		N/A
-4.19%		N/A
-43.90%		N/A
54.16%		N/A
248.23%		N/A
73.85%		N/A
32.45%		N/A
42.25%		N/A
84.64%
Operating Margin
MNPR operating margin by date.MNPR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MNPR eps by date.MNPR eps by date.
N/AN/AN/AN/A-2.95
-48.32%		-3.70
-25.42%		-4.15
-12.16%		-3.05
26.51%		-4.12
-35.08%		N/A
47.76%		N/A
-65.88%		N/A
86.86%		N/A
485.87%		N/A
63.94%		N/A
-12.71%		N/A
5.71%		N/A
13.22%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth		-0.48
3.71%		-0.51
-37.84%		-0.70
74.50%		-0.56
-46.74%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-4.067M
-127.20%		-4.386M
-178.49%		-5.071M
54.21%		-4.359M
-35.31%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 -0.38
24.00%		-0.690.3145.21%
Q4 2024
Q2Q % growth		 -2.75
-358.33%		-0.43-2.32-541.92%
Q3 2024
Q2Q % growth		 -0.37
47.14%		-0.490.1223.90%
Q2 2024
Q2Q % growth		 -0.50
37.50%		-0.48-0.02-5.05%
Q1 2024
Q2Q % growth		 -0.50
47.37%		-0.610.1118.30%
Q4 2023
Q2Q % growth		 -0.60
47.83%		-0.790.1924.10%
Q3 2023
Q2Q % growth		 -0.70
26.32%		-0.870.1719.26%
Q2 2023
Q2Q % growth		 -0.80
27.27%		-0.940.1414.75%
Q1 2023
Q2Q % growth		 -0.95 -1.130.1816.09%
Q4 2022
Q2Q % growth		 -1.15
-9.52%		-1.05-0.10-10.00%
Q3 2022
Q2Q % growth		 -0.95
5.00%		-1.110.1614.36%
Q2 2022
Q2Q % growth		 -1.10
-29.41%		-1.05-0.05-4.36%
Q1 2022
Q2Q % growth		 -0.95
-18.75%		-1.130.1816.28%
Q4 2021
Q2Q % growth		 -1.05
-5.00%		-0.97-0.08-8.36%
Q3 2021
Q2Q % growth		 -1.00
-33.33%		-1.080.087.73%
Q2 2021
Q2Q % growth		 -0.85
-21.43%		-0.980.1313.42%
Q1 2021
Q2Q % growth		 -0.80
-60.00%		-0.950.1515.97%
Q4 2020
Q2Q % growth		 -1.00
-53.85%		-0.96-0.04-4.58%
Q3 2020
Q2Q % growth		 -0.75 -0.780.034.09%
Q2 2020
Q2Q % growth		 -0.70 -0.46-0.24-52.51%
Q1 2020
Q2Q % growth		 -0.50 -0.560.0610.87%
Q4 2019
Q2Q % growth		 -0.65 -0.36-0.29-82.07%
MNPR Yearly EPS VS EstimatesMNPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MNPR Yearly Revenue VS EstimatesMNPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS15.71% 18.97% 6.22% 18.85%
RevenueN/A N/A N/A N/A